A critical review of Cernitin for Symptomatic Relief of Lower Urinary tract symptoms (LUTS) in Men A Critical Review of PollenAid for Symptomatic Relief of Lower Urinary Tract Symptoms (LUTS) in Men

A Critical Review of Cernitin for Symptomatic Relief of Lower Urinary Tract Symptoms (LUTS) in Men A Critical Review of Cernitin for Symptomatic Relief Of Lower Urinary Tract Symptoms (LUTS) in Men

A critical review of Cernitin for Symptomatic Relief of Lower Urinary tract symptoms (LUTS) in Men A Critical Review of CernitinTM for Symptomatic Relief of Lower Urinary Tract Symptoms (LUTS) in Men

1 Department of Physiology and Biophysics, Georgetown University Medical Center, Washington, D.C. USA 2 Department of Pharmacy Sciences, School of Pharmacy and Health Professions, Creighton University Medical Center, Omaha, NE. USA 3 National Center for Natural Products Research, and Department of Pharmaceutics, University of Mississippi, Research Institute of Pharmaceutical Sciences, School of...

A critical review of Graminex Flower Pollen Extract for Symptomatic Relief of Lower Urinary tract symptoms (LUTS) in Men A Critical Review of Graminex Flower pollen extract for Symptomatic Relief of Lower Urinary Tract Symptoms (LUTS) in Men

The National Institutes of Health (NIH) estimates 9 million men suffer from symptoms related to an enlarged prostate and 400,000 surgeries are conducted each year in the U.S. 1 The term lower urinary tract symptoms (LUTS) is used to describe symptomatology in men who are experiencing one or more symptoms on the International Prostate Symptom Score (IPSS) questionnaire that includes urgency, day...

Tadalafil in the treatment of lower urinary tract symptoms and erectile dysfunction

10.2217/14750708.5.3.355 © 2 In the aging male, erectile dysfunction (ED) and lower urinary tract symptoms (LUTS) are common conditions that have been shown to be related. As life expectancy increases, treatments that target both ED and LUTS will prove increasingly valuable over the coming years. Phosphodiesterase type 5 (PDE5) inhibitors are used primarily to treat ED. Recently, studies have s...

When to Treat the Prostate, the Bladder, or Both?

Context: Pharmacological therapy for relieving lower urinary tract symptoms suggestive of benign prostatic hyperplasia (LUTS/BPH) has evolved during the past years. The possible benefits of combination therapies to prevent disease progression or to treat LUTS/BPH with concomitant overactive bladder (OAB) or erectile dysfunction (ED) are currently studied. Objectives: To review the evidence prov...